Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas V Faller

Showing results (21-30 of 126) with videos related to

Pageof 13
Sort By:
Leukemia Research|February 29, 2024
A critical evaluation of the EFS endpoint in AML: Does induction treatment failure timing have a profound impact on study design and results?Yulia Sidi, Cassie Dong, Yujun Wu, et al.
Anti-Cancer Drugs|May 6, 2008
Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicityAndrew M Rankin, Douglas V Faller, Remco A Spanjaard
Hematology/Oncology Clinics of North America|March 5, 2014
Targeted fetal hemoglobin induction for treatment of beta hemoglobinopathiesSusan P Perrine, Betty S Pace, Douglas V Faller
Virology|May 22, 2003
Mutations that abrogate transactivational activity of the feline leukemia virus long terminal repeat do not affect virus replicationAna L Abujamra, Douglas V Faller, Sajal K Ghosh
FEBS Letters|November 6, 2007
Loss of putative tumor suppressor EI24/PIG8 confers resistance to etoposideChristina N Mork, Douglas V Faller, Remco A Spanjaard
Cellular Signalling|January 17, 2009
PKCdelta survival signaling in cells containing an activated p21Ras protein requires PDK1Shuhua Xia, Zhihong Chen, Lora W Forman, et al.
Nucleic Acid Therapeutics|August 27, 2013
Enhanced cytotoxicity from deoxyguanosine-enriched T-oligo in prostate cancer cellsAndrew M Rankin, Lora Forman, Sibaji Sarkar, et al.
Cellular Signalling|July 24, 2002
The role of Ras in T lymphocyte activationPeihong Ma, Maureen Magut, Douglas V Faller, et al.
The Laryngoscope|August 2, 2002
Differential effects of short-chain fatty acids on head and neck squamous carcinoma cellsSrinivasan Krishna, Neil Brown, Douglas V Faller, et al.
BMC Cancer|February 18, 2014
Protein kinase C-δ inactivation inhibits the proliferation and survival of cancer stem cells in culture and in vivoZhihong Chen, Lora W Forman, Robert M Williams, et al.
Pageof 13

Showing results (21-30 of 126) with videos related to

Sort By:
Pageof 13
Leukemia Research|February 29, 2024
A critical evaluation of the EFS endpoint in AML: Does induction treatment failure timing have a profound impact on study design and results?Yulia Sidi, Cassie Dong, Yujun Wu, et al.
Anti-Cancer Drugs|May 6, 2008
Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicityAndrew M Rankin, Douglas V Faller, Remco A Spanjaard
Hematology/Oncology Clinics of North America|March 5, 2014
Targeted fetal hemoglobin induction for treatment of beta hemoglobinopathiesSusan P Perrine, Betty S Pace, Douglas V Faller
Virology|May 22, 2003
Mutations that abrogate transactivational activity of the feline leukemia virus long terminal repeat do not affect virus replicationAna L Abujamra, Douglas V Faller, Sajal K Ghosh
FEBS Letters|November 6, 2007
Loss of putative tumor suppressor EI24/PIG8 confers resistance to etoposideChristina N Mork, Douglas V Faller, Remco A Spanjaard
Cellular Signalling|January 17, 2009
PKCdelta survival signaling in cells containing an activated p21Ras protein requires PDK1Shuhua Xia, Zhihong Chen, Lora W Forman, et al.
Nucleic Acid Therapeutics|August 27, 2013
Enhanced cytotoxicity from deoxyguanosine-enriched T-oligo in prostate cancer cellsAndrew M Rankin, Lora Forman, Sibaji Sarkar, et al.
Cellular Signalling|July 24, 2002
The role of Ras in T lymphocyte activationPeihong Ma, Maureen Magut, Douglas V Faller, et al.
The Laryngoscope|August 2, 2002
Differential effects of short-chain fatty acids on head and neck squamous carcinoma cellsSrinivasan Krishna, Neil Brown, Douglas V Faller, et al.
BMC Cancer|February 18, 2014
Protein kinase C-δ inactivation inhibits the proliferation and survival of cancer stem cells in culture and in vivoZhihong Chen, Lora W Forman, Robert M Williams, et al.
Pageof 13